CytomX Therapeutics, Inc. (FRA:6C1)
Germany · Delayed Price · Currency is EUR 4.876
+0.470 (10.67%)
Last updated: Jan 28, 2026, 8:02 AM CET
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of €811.47 million as of January 30, 2026. Its market cap has increased by 1,143.46% in one year.
Market Cap
811.47M
Enterprise Value
695.29M
Revenue
96.85M
Ranking
n/a
PE Ratio
33.98
Stock Price
€4.88
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from 399.33M to 811.47M, an increase of 103.21%. That is a compound annual growth rate of 7.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 811.47M | 32.00% |
| Dec 31, 2025 | 614.75M | 689.58% |
| Dec 31, 2024 | 77.86M | -17.12% |
| Dec 29, 2023 | 93.94M | -5.05% |
| Dec 30, 2022 | 98.94M | -60.18% |
| Dec 31, 2021 | 248.43M | 0.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |
| Northern Data AG | 815.30M |
| Paul Hartmann AG | 774.28M |
| EUROKAI GmbH & Co. KGaA | 697.65M |
| FRoSTA Aktiengesellschaft | 658.10M |